Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

CME Gr Q3 Adj. EPS $2.68 Beats $2.63 Estimate, Sales $1.538B Beat $1.531B Estimate

Author: Benzinga Newsdesk | October 22, 2025 07:01am
CME Gr (NASDAQ:CME) reported quarterly earnings of $2.68 per share which beat the analyst consensus estimate of $2.63 by 1.79 percent. This is unchanged from the same period last year. The company reported quarterly sales of $1.538 billion which beat the analyst consensus estimate of $1.531 billion by 0.49 percent. This is a 2.90 percent decrease over sales of $1.584 billion the same period last year.

Posted In: CME


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist